336 related articles for article (PubMed ID: 1991714)
1. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
Perera LP; Samuel JE; Holmes RK; O'Brien AD
J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
[TBL] [Abstract][Full Text] [Related]
2. Mapping the minimal contiguous gene segment that encodes functionally active Shiga-like toxin II.
Perera LP; Samuel JE; Holmes RK; O'Brien AD
Infect Immun; 1991 Mar; 59(3):829-35. PubMed ID: 1997433
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
[TBL] [Abstract][Full Text] [Related]
4. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.
Weinstein DL; Jackson MP; Samuel JE; Holmes RK; O'Brien AD
J Bacteriol; 1988 Sep; 170(9):4223-30. PubMed ID: 3045088
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli cytotoxins and enterotoxins.
Gyles CL
Can J Microbiol; 1992 Jul; 38(7):734-46. PubMed ID: 1393838
[TBL] [Abstract][Full Text] [Related]
6. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.
Lindgren SW; Samuel JE; Schmitt CK; O'Brien AD
Infect Immun; 1994 Feb; 62(2):623-31. PubMed ID: 8300218
[TBL] [Abstract][Full Text] [Related]
7. Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity.
Yamasaki S; Furutani M; Ito K; Igarashi K; Nishibuchi M; Takeda Y
Microb Pathog; 1991 Jul; 11(1):1-9. PubMed ID: 1795624
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.
Austin PR; Jablonski PE; Bohach GA; Dunker AK; Hovde CJ
Infect Immun; 1994 May; 62(5):1768-75. PubMed ID: 8168939
[TBL] [Abstract][Full Text] [Related]
9. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
Weinstein DL; Jackson MP; Perera LP; Holmes RK; O'Brien AD
Infect Immun; 1989 Dec; 57(12):3743-50. PubMed ID: 2807546
[TBL] [Abstract][Full Text] [Related]
10. Purification of recombinant shiga-like toxin type I B subunit.
Austin PR; Hovde CJ
Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
[TBL] [Abstract][Full Text] [Related]
12. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli.
Sung LM; Jackson MP; O'Brien AD; Holmes RK
J Bacteriol; 1990 Nov; 172(11):6386-95. PubMed ID: 2228965
[TBL] [Abstract][Full Text] [Related]
13. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.
Strockbine NA; Jackson MP; Sung LM; Holmes RK; O'Brien AD
J Bacteriol; 1988 Mar; 170(3):1116-22. PubMed ID: 2830229
[TBL] [Abstract][Full Text] [Related]
14. Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples.
Schmidt H; Montag M; Bockemühl J; Heesemann J; Karch H
Infect Immun; 1993 Feb; 61(2):534-43. PubMed ID: 8423084
[TBL] [Abstract][Full Text] [Related]
15. Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant of Shiga-like toxin II with synthetic oligonucleotide probes.
Brown JE; Sethabutr O; Jackson MP; Lolekha S; Echeverria P
Infect Immun; 1989 Sep; 57(9):2811-4. PubMed ID: 2668189
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits.
Jackson MP; Deresiewicz RL; Calderwood SB
J Bacteriol; 1990 Jun; 172(6):3346-50. PubMed ID: 2345150
[TBL] [Abstract][Full Text] [Related]
17. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons.
Paton AW; Bourne AJ; Manning PA; Paton JC
Infect Immun; 1995 Jul; 63(7):2450-8. PubMed ID: 7790056
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis.
Jemal C; Haddad JE; Begum D; Jackson MP
J Bacteriol; 1995 Jun; 177(11):3128-32. PubMed ID: 7768810
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.
Calderwood SB; Auclair F; Donohue-Rolfe A; Keusch GT; Mekalanos JJ
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4364-8. PubMed ID: 3299365
[TBL] [Abstract][Full Text] [Related]
20. Identification of the Shiga toxin A-subunit residues required for holotoxin assembly.
Haddad JE; Jackson MP
J Bacteriol; 1993 Dec; 175(23):7652-7. PubMed ID: 8244934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
